RecruitingNot ApplicableNCT06183281

Integrating Nonpharmacologic Strategies for Pain With Inclusion, Respect, and Equity

Integrating Nonpharmacologic Strategies for Pain With Inclusion, Respect, and Equity (INSPIRE): Tailored Digital Tools, Telehealth Coaching, and Primary Care Coordination


Sponsor

University of California, San Francisco

Enrollment

586 participants

Start Date

Apr 28, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

INSPIRE creates a trilingual mobile app and telehealth coaching program to promote non-pharmacologic strategies for pain management with Black, Chinese, and Latinx communities in the San Francisco Bay Area. Years 1-2 will develop the app and test it with a brief single arm pilot starting in Nov 2023. A full two arm randomized controlled trial (RCT) will being in early 2025 with changes in PEG scores as the primary outcome. Secondary outcomes include Helping to End Addiction Longterm (HEAL) common data elements.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called CBT, Mindfulness, and Movement for people with chronic pain. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALCBT, Mindfulness, and Movement

Blended CBT, mindfulness, and movement delivered through a mobile app and supported by a weekly telehealth pain management coach.


Locations(2)

San Francisco General Hospital

San Francisco, California, United States

UCSF Adult Primary Care Mt. Zion Clinic

San Francisco, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06183281


Related Trials